StockWatch
·

RELIANCE INDUSTRIES LTD. Q4 FY26 Results

RELIANCEQ4 FY26 Results
Filing
MetricValue ( Cr)Q3 FY26Q4 FY25
Revenue3.0L10.8%12.9%
Total Income3.0L10.4%12.5%
Expenditure2.8L12.7%14.8%
PBT27.2K8.4%6.6%
Net Profit20.6K7.6%8.9%
OPM14.78%2.30pp1.79pp
NPM6.79%1.33pp1.60pp
EPS12.549.0%12.6%
View full financials

RIL reports record annual PAT \u20b995,610 Cr, up 18.3% YoY; Revenue \u20b91.17T

24 Apr 2026 · 24 Apr, 7:55 pm

Summary

Reliance Industries Limited delivered a strong financial performance for the quarter and year ended March 31, 2026, reporting a record annual consolidated Profit After Tax of ₹ 95,610 crore, up 18.3% year-on-year. This was supported by record annual consolidated revenue of ₹ 1,175,919 crore, which grew by 9.8% Y-o-Y, and a record annual consolidated EBITDA of ₹ 207,911 crore, marking a 13.4% increase Y-o-Y. Key segments like Jio Platforms and Reliance Retail demonstrated robust operational growth, with Jio's subscriber base surpassing 524 million and Reliance Retail's store count exceeding 20,000. The company also declared a dividend of ₹ 6/- per share for its shareholders.

Key Highlights

  1. 1

    Reliance Industries Limited reported a record annual consolidated Profit After Tax (PAT) of ₹ 95,610 crore for FY26, marking an 18.3% increase year-on-year.

  2. 2

    Record Annual Consolidated Revenue reached ₹ 1,175,919 crore for FY26, representing a 9.8% growth Y-o-Y.

  3. 3

    Record Annual Consolidated EBITDA for FY26 stood at ₹ 207,911 crore, up 13.4% Y-o-Y.

  4. 4

    Jio Platforms achieved a 17.9% Y-o-Y increase in EBITDA for Q4 FY26, reaching ₹ 20,060 crore, with its margin expanding by 230 bps.

  5. 5

    Reliance Retail's EBITDA for Q4 FY26 grew by 3.1% Y-o-Y to ₹ 6,921 crore, and its store count successfully crossed the 20,000 mark.

  6. 6

    Jio's total subscriber base exceeded 524 million, with 268 million subscribers now on Jio True5G.

  7. 7

    The company announced a dividend of ₹ 6/- per share.

Informational and educational content only. Not investment advice.